Past Event: July 2013 - Dr Chris Roberts, CEO of Cochlear
Will regulation kill innovation
Topic: Technologic Innovation and what it means to Cochlear
Date: 31 July 2013
Speaker: Dr Chris Roberts, CEO of Cochlear
Dr Chris Roberts addressed questions such as:
- Why is innovation, and specifically technologic innovation, the turbocharger of growth for a company or a country?
- And if it is, why isn't it front and centre in the debate about how we design our society for sustainable growth?
- How does a company like Cochlear Limited think about innovation? How is technology incorporated in the company's DNA?
- Why did Cochlear want to relocate to a major University campus?
Professor Paul Gollan gave a 'Welcome to Country' and a brief introduction to the visions of the Faculty of Business and Economics, and the Thought Leadership Series.
Professor David Wilkinson gave a brief welcome and introduction to the inaugural Macquarie University Thought Leadership Series.
Dr Chris Roberts
Dr Chris Roberts has been the CEO of Cochlear Limited since February 2004. He has over 36 years experience in the international medical device industry including renal dialysis, orthopaedics, cardiology, respiratory and sleep medicine and otology.
He served on the National Health and Medical Research Council Australia from 2003 to 2006 and is Director of ResMed Limited and Research Australia. He is a member of the New South Wales Innovation and Productivity Council, the UNSW Faculty of Medicine Advisory Council, the Macquarie University Foundation Board of Patrons and the University of Technology Sydney Vice-Chancellors Industrial Advisory Board.
Dr Roberts holds a BE in Chemical Engineering from UNSW, an MBA from Macquarie University, a PHD from UNSW and an HonDSc from Macquarie University.